Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
Lario Therapeutics has raised $2.4M in total funding. The most recent round was Grant. The last funding was announced in February 2026.
Lario Therapeutics's investors include Wellcome Trust, Michael J. Fox Foundation.
Lario Therapeutics is headquartered in Edinburgh, United Kingdom.
Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
Lario Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lario Therapeutics — Funding & Investors." VCBacked, February 19, 2026, https://www.vcbacked.co/company/lario-therapeutics. Accessed August 14, 2026.
VCBacked. (2026). Lario Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/lario-therapeutics
{{cite web |title=Lario Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lario-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated